Methods and apparatus for detecting and reacting to insufficient hypoglycemia response

1. A system for providing blood glucose data, the system comprising:

an insulin delivery pump; and

a controller comprising a system memory element and at least one processor, the controller communicatively coupled to the insulin delivery pump, and the controller configured to:

cause suspension of a continuous basal insulin delivery by the insulin delivery pump prior to glucose levels falling into a hypoglycemic range;

in response to the suspension of the continuous basal insulin delivery by the insulin delivery pump:

predict that the suspension of the continuous basal insulin delivery will be insufficient to prevent the glucose levels from falling into the hypoglycemic range and thereby identify a condition in which the glucose levels will continue to decrease after the suspension of the continuous basal insulin delivery, wherein the controller is further configured to identify the condition by:

obtaining an insulin on board (IOB) value, via the insulin delivery pump, wherein the IOB value is a quantity of insulin remaining in a body of a user following a bolus of insulin provided by the insulin delivery pump;

scaling a total daily dose (TDD) value by a factor, to generate a result having a value that is less than the TDD value, wherein the TDD value is a quantity of insulin required by the user in a twenty-four hour period; and

determining that the IOB value is greater than the result, wherein the condition comprises the IOB value being greater than the result; and

initiate performance of an action by the insulin delivery pump, in response to identifying the condition in which the glucose levels will continue to decrease after the suspension of the continuous basal insulin delivery, for preventing the glucose levels from falling into the hypoglycemic range in combination with the suspension of the continuous basal insulin delivery.

2. The system of claim 1 , wherein the controller is integrated into the insulin delivery pump, and wherein the system comprises a device including the controller and the insulin delivery pump.

3. The system of claim 1 , wherein the controller is further configured to:

identify a problematic glucose trend indicative of leading to hypoglycemic levels, via the insulin delivery pump, and

wherein the suspension of the continuous basal insulin delivery is based on the problematic glucose trend.

4. The system of claim 1 , wherein the controller is further configured to identify the condition by:

calculating a glucose trend value, using the insulin delivery pump; and

determining that the glucose trend value is less than a predetermined threshold that indicates hypoglycemia, wherein the condition further comprises the glucose trend value being less than the predetermined threshold, the condition indicating that blood glucose levels will continue to decrease when the continuous basal insulin delivery is suspended thereby inducing hypoglycemia.

5. The system of claim 4 , wherein the insulin delivery pump is further configured to collect a plurality of sensor glucose values; and

wherein the controller is further configured to calculate the glucose trend value by computing a derivative of the plurality of sensor glucose values, and wherein the glucose trend value comprises the derivative.

6. The system of claim 1 , wherein the controller is further configured to initiate providing, by the insulin delivery pump, a glucagon injection, in response to identifying the condition, and wherein the action comprises providing the glucagon injection.

7. The system of claim 1 , wherein the controller is further configured to present an alert comprising at least one of an audio alert and a visual alert, and wherein the action comprises presenting the alert.

8. The system of claim 1 , wherein the glucose levels falling into the hypoglycemic range is a predicted hypoglycemic event, and wherein the condition indicates that the predicted hypoglycemic event will continue after the continuous basal insulin delivery is suspended.

9. The system of claim 8 , wherein the condition indicating that the predicted hypoglycemic event will continue after the continuous basal insulin delivery is suspended also indicates that the predicted hypoglycemic event is not rectifiable by suspending the continuous basal insulin delivery.

10. The system of claim 8 , wherein the action addresses the predicted hypoglycemic event.